Scientists at Cognigenics have made a significant advance in the field of neuroscience and mental health treatment. Their groundbreaking research, published in Genomic Psychiatry, demonstrates that a new RNA-based therapy called COG-201 can enhance memory and reduce anxiety in animal models.
Data: Key to Unlocking Better Behavioral Health Outcomes
Sarah Reilly, SVP, Product and Strategy, Lucet The growing demand for behavioral healthcare in America is putting a serious strain on both payers and providers